Lenalidomide-C10-OH

• Description :

  Lenalidomide-C10-OH (6a) is an intermediate in the synthesis of INY-03-041[1].

• UNSPSC :

  12352005

• Target :

  Drug Intermediate

• Type :

  Reference compound

• Related Pathways :

  Others

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/lenalidomide-c10-oh.html

• Purity :

  91.54

• Solubility :

  DMSO : 110 mg/mL (ultrasonic; warming; heat to 80°C)

• Smiles :

  O=C(C(N(CC1=C2C=CC=C1CCCCCCCCCCO)C2=O)CC3)NC3=O

• Molecular Formula :

  C23H32N2O4

• Molecular Weight :

  400.51

• References & Citations :

  [1]You I, et, al. Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling. Cell Chem Biol. 2020 Jan 16;27 (1) :66-73.e7.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2503018-12-8]